Improvement of respiratory symptoms and health‐related quality of life with peramivir in influenza patients with chronic respiratory disease: Additional outcomes of a randomized, open‐label study

BACKGROUND: To compare peramivir 300 mg single‐dose, peramivir 600 mg repeat‐dose, and oseltamivir effects on health‐related quality of life, including respiratory symptoms and general conditions, time to symptom alleviation, time to fever resolution, incidence of exacerbations, and virus titer, in...

Descripción completa

Detalles Bibliográficos
Autores principales: Kato, Motokazu, Saisho, Yutaka, Tanaka, Hiroshi, Bando, Takuma
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8404055/
https://www.ncbi.nlm.nih.gov/pubmed/33683019
http://dx.doi.org/10.1111/irv.12835

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8404055/
https://www.ncbi.nlm.nih.gov/pubmed/33683019
http://dx.doi.org/10.1111/irv.12835

Ejemplares similares